Jump to content

User:Dr Aaron

From Wikipedia, the free encyclopedia
(Redirected from User:Aarons@chw.edu.au)

Dr Aaron is a medical researcher based in Australia. His scientific background is cell biology, molecular biology, and developmental biology, with a particular focus on muscle and the heart.

He is currently working in the field of orthopaedic (bone) research. He has several research focuses including the application of bisphosphonates for treating orthopaedic complications; study of the skeletal defects associated with Neurofibromatosis type 1; and bone tissue engineering.

He also makes contributions to movies, books, and other forms of popular culture.

Scientific Contributions

[edit]

Cell biology: Adult stem cell, Bone cells, Allograft, Autograft, Cell culture, Cell nucleus, Cell therapy, Cellular differentiation, Embryonic stem cell, Explant culture, Growth Factor, Mesenchymal stem cell, Mesoangioblast, Osteoblast, Pericyte, Pluripotency, Progenitor cell, Satellite cells, Stem cell, Stem cell controversy, Tissue culture

Molecular biology: Adenosine triphosphate, Cre-Lox recombination, Immunofluorescence, Immunohistochemistry, Immunoperoxidase, Immunostaining, Molecular Biology, Real-time polymerase chain reaction, Site-specific recombinase technology

Genes, Proteins, Drugs, & Diseases: Bisphosphonates, Bone morphogenetic protein, Bone morphogenetic protein 2, Bone morphogenetic protein 7, Collagen, Cre recombinase, Myf5, MyoD, Neurofibromatosis, Neurofibromatosis type 1, Osteogenesis imperfecta, Osteoporosis, p16 (gene), Cbfa1/Runx2, Sclerostin, Zoledronate

Scientists & Institutions: Robert Lanza, the Victor Chang Cardiac Research Institute

Non-scientific Contributions

[edit]

Byron (Babylon 5), The Crystal Palace (novel), Ghost Riders (wine), Juliet Marillier, Kiddy Grade, Howl's Moving Castle, List of Kiddy Grade episodes, Wikipedia:Manual of Style (writing about fiction) | Talk | Draft Revision, Phyllis Eisenstein, Sorcerer's Son, Spellforce 2: Shadow Wars


Bold indicates a major contribution was made to this page

Italics indicates the creation of a new page